NASDAQ
Revive Therapeutics Ltd. (RVVTF) has a current ratio of 0.02x as of Tuesday, May 26, 2026. This represents a 99.74% decrease compared to its 12-month average of 7.53x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.